Scientific Industries Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Scientific Industries Inc (SCND) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Scientific Industries Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 6M vs 131,147M combined for tracked competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+2.7% annualized vs trailing 12 months), vs accelerating (+12.4%) for its tracked peer group.
- Growth: Scientific Industries Inc generated 36.0% revenue growth year over year in Q2 2026, vs 29.4% for its tracked competitors combined.
- Profitability: Its -83.9% net margin compares with 12.5% for the peer group.
- Scale: Scientific Industries Inc ranks #26 of 32 companies by market capitalization in the Laboratory Analytical Instruments industry, holding 0.0% of industry market cap.
- Peer revenue share: Scientific Industries Inc accounted for 0.0% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.03M compares with $0.66M for the peer group (0.0x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
SCND Sales vs. its Competitors, Q2 2026
Scientific Industries Inc reported revenue growth of 36.02 % year on year in Q2 2026, above its competitors' combined revenue growth of 29.38 %.
With a net margin of -83.91 %, Scientific Industries Inc reported lower profitability than its competitors (12.51 %).
Scientific Industries Inc generated 0.00 % of the combined sales of its peer group, up from 0.00 % a year earlier.
Scientific Industries Inc vs. its Competitors, Q2 2026
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Scientific Industries Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Scientific Industries Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (1) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (5) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (5) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Scientific Industries Inc's competitor groups requires a Commercial License.
For context: the Laboratory Analytical Instruments industry grew revenue 13.3% year over year, combined, vs 36.0% for Scientific Industries Inc. Scientific Industries Inc's share of combined industry revenue moved from 0.01% to 0.01%, a gain of 0.00 percentage points.
Scientific Industries Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Scientific Industries Inc | No | No | No | No |
| Competitors combined (19) | ||||
| High-Confidence Competitors (1) | ||||
| Similar-Size Competitors (7) | ||||
| Similar Growth & Profitability (8) | 12.50 % (1 of 8) | 50.00 % (4 of 8) | 37.50 % (3 of 8) | 37.50 % (3 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
SCND Stock Performance relative to its Competitors
SCND Stock Performance relative to High-Confidence Competitors
SCND Stock Performance relative to Similar-Size Competitors
SCND Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | 10x Genomics Inc | 282.9% | Outperformed |
| 2 | Illumina Inc | 282.9% | Outperformed |
| 3 | Bruker Corporation | 282.9% | Outperformed |
| 4 | Harvard Bioscience Inc | 282.9% | Outperformed |
| 5 | Revvity Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Scientific Industries Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Scientific Industries Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Scientific Industries Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Scientific Industries Inc | 8.95 | 5.73 |
| Thermo Fisher Scientific Inc | 251,760.60 | 46,336.00 |
| Enterprise Products Partners L p | 80,080.25 | 58,471.00 |
| Agilent Technologies inc | 49,584.43 | 7,372.00 |
| Illumina Inc | 41,600.70 | 4,493.00 |
| Mettler toledo International Inc | 31,162.17 | 4,133.88 |
| SUBTOTAL | 514,707.45 | 137,784.67 |
Sign in to see all competitors of Scientific Industries Inc .
Sources: Scientific Industries Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Scientific Industries Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Scientific Industries Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Applikon Biotechnology, B.V. | Named by the company | 85% |
| Eppendorf SE | Named by the company | 85% |
| Micromeritics Instrument Corporation | Named by the company | 85% |
| Sartorius AG | Named by the company | 85% |
| Adam Equipment Co., Ltd. | Named by the company | 85% |
| Capsa Healthcare | Named by the company | 85% |
| Illinois Tool Works | Named by the company | 85% |
| PreSens GmbH | Named by the company | 85% |
| Avery Weigh-Tronix | Named by the company | 85% |
| Hamilton Bonaduz AG | Named by the company | 85% |
| Ohaus Corporation | Named by the company | 85% |
| Anton Paar | Named by the company | 85% |
| DASGIP Technology GmbH | Named by the company | 85% |
| Medility Inc. | Named by the company | 85% |
| PyroScience GmbH | Named by the company | 85% |
| ABER Instruments | Named by the company | 85% |
| Benchmark Scientific, Inc. | Named by the company | 85% |
| Heidolph Instruments GmbH | Named by the company | 85% |
| optek-Danulat GmbH | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Scientific Industries Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Scientific Industries Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Scientific Industries Inc | Consolidated Entity 100.00 % |
| Thermo Fisher Scientific Inc | Clinical Research 19.98 % |
| Enterprise Products Partners L p | Petrochemical and Refined Products Services 73.80 % |
| Agilent Technologies inc | Agilent CrossLab 41.36 % |
| Illumina Inc | Sequencing 90.94 % |
| Mettler toledo International Inc | US Operations 34.31 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Scientific Industries Inc .
Scientific Industries Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Scientific Industries Inc | 9 | 28,357 | -6,447 |
| Thermo Fisher Scientific Inc | 251,761 | 370,688 | 55,912 |
| Enterprise Products Partners L p | 80,080 | - | - |
| Agilent Technologies inc | 49,584 | 407,293 | 79,558 |
| Illumina Inc | 41,601 | 3,510,156 | 644,531 |
| Mettler toledo International Inc | 31,162 | 249,029 | 54,555 |
| PEERS TOTAL | 514,699 | 661,632 | 76,545 |
Sign in to see all peers for Scientific Industries Inc .
Scientific Industries Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Thermo Fisher Scientific Inc | North America 51.27 % |
| Agilent Technologies inc | Americas 41.63 % |
| Illumina Inc | United States and Canada 56.34 % |
| Mettler toledo International Inc | Us Operations segment 34.31 % |
| 10x Genomics Inc | United States 54.36 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Scientific Industries Inc .
Scientific Industries Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 28 companies in Scientific Industries Inc's industry classification, broader than the peer set above. Market cap in millions of $.Scientific Industries Inc ranks #26 of 28 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,482, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Agilent Technologies inc | 49,584 | 21.65 % |
| 2 | Waters Corporation | 43,498 | 18.99 % |
| 3 | Illumina Inc | 41,601 | 18.16 % |
| 4 | Mettler toledo International Inc | 31,162 | 13.61 % |
| 5 | Revvity Inc | 1,234 | 5.2% |
| 6 | 10x Genomics Inc | 1,234 | 5.2% |
| 7 | Avantor Inc | 1,234 | 5.2% |
| 8 | Bio rad Laboratories Inc | 1,234 | 5.2% |
| 9 | Bruker Corporation | 1,234 | 5.2% |
| 10 | Alamar Biosciences Inc | 1,234 | 5.2% |
| 26 | Scientific Industries Inc | 9 | 0.00 % |
Market cap and industry share for the rest of Scientific Industries Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-25.
Scientific Industries Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 21 | Precipio inc | 43 | 34.58 % |
| 22 | Harvard Bioscience Inc | 36 | 80.91 % |
| 23 | Bionano Genomics Inc | 19 | -4.09 % |
| 24 | Astrotech Corp | 1,234 | 12.3% |
| 25 | Lifeloc Technologies Inc | 1,234 | 12.3% |
| 26 | Scientific Industries Inc | 9 | - |
| 27 | Reflect Scientific Inc | 1,234 | 12.3% |
| 28 | Thermogenesis Holdings Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Scientific Industries Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-28. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Scientific Industries Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Laboratory Analytical Instruments industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (45 companies). See the full Laboratory Analytical Instruments industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 29.18 % | 40.40 % (avg) | -11.2 pp |
| Operating Margin | -125.62 % | industry median | -112.5 pp |
| EBITDA Margin | -39.85 % | -18.51 % (avg) | -21.3 pp |
| Capital Intensity (Capex / Revenue) | 0.78 % | 3.93 % (avg) | -3.1 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Scientific Industries Inc's Valuation vs Competitive Position
Valuation multiples vs the Laboratory Analytical Instruments industry average (45 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Laboratory Analytical Instruments industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 34.1x | - |
| EV / EBITDA | - | 22.1x | - |
| P/B | 0.8x | 2.6x | -1.8x |
| Return on Equity | -12.92 % | industry aggregate | -21.70 % |
| Return on Invested Capital | -34.79 % | -11.56 % (avg) | -23.23 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Scientific Industries Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2019 | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue Growth | - | - | 16.28 % | -0.93 % | -3.59 % | -27.50 % |
| Operating Margin | 15.97 % | -17.75 % | -70.38 % | -83.34 % | -61.97 % | -97.99 % |
| Return on Invested Capital | -167.03 % | -7.70 % | -16.64 % | -36.81 % | -28.91 % | -38.07 % |
| P/E | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Scientific Industries Inc's Strategic Group Map
Every company in Scientific Industries Inc's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Scientific Industries Inc is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Scientific Industries Inc's BCG Growth-Share Matrix
Relative market share (vs Scientific Industries Inc's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Scientific Industries Inc falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 4.6% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Scientific Industries Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 1,482 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.78 % vs industry average 3.93 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Scientific Industries Inc's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Scientific Industries Inc's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Scientific Industries Inc's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Scientific Industries Inc falls in the Low attractiveness / Low strength cell: Harvest / Divest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Scientific Industries Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Latest-quarter revenue run-rate is accelerating (+2.7% annualized vs trailing 12 months).
Weaknesses
- Operating margin 112.5 points below the industry median.
- Return on equity 21.7 points below the industry aggregate.
- Low relative market share vs the industry leader (0.00x).
Opportunities
- A meaningful share of tracked competitors (50.00 %) show financial-distress signals, a possible opening to gain share.
Threats
No rule matched.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Scientific Industries Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Scientific Industries Inc | - | 6.62 | - |
| Thermo Fisher Scientific Inc | 0.32 | 1.62 | 0.78 |
| Enterprise Products Partners L p | 0.04 | 0.93 | 1.30 |
| Agilent Technologies inc | 0.77 | 2.02 | 1.02 |
| Illumina Inc | - | 1.74 | 0.75 |
| Mettler toledo International Inc | 0.04 | 1.13 | - |
Sign in to see all peers for Scientific Industries Inc .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Scientific Industries Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Scientific Industries Inc | Q2 2026 | +36.0 % | - |
| Thermo Fisher Scientific Inc | Q2 2026 | +10.5 % | +7.6 % |
| Enterprise Products Partners L p | Q2 2026 | +60.8 % | +27.6 % |
| Agilent Technologies inc | Q2 2026 | +8.1 % | +7.7 % |
| Illumina Inc | Q2 2026 | +9.4 % | -11.9 % |
| Mettler toledo International Inc | Q2 2026 | +4.5 % | +15.1 % |
| PEERS TOTAL | +27.8 % | +11.4 % |
Sign in to see all peers for Scientific Industries Inc .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Scientific Industries Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Scientific Industries Inc | Q2 2026 | +20.4 % | +20.3 % |
| Thermo Fisher Scientific Inc | Q2 2026 | +142.5 % | +53.1 % |
| Enterprise Products Partners L p | Q2 2026 | +79.3 % | -10.9 % |
| Agilent Technologies inc | Q2 2026 | -1.6 % | -22.3 % |
| Illumina Inc | Q2 2026 | +6.9 % | +33.3 % |
| Mettler toledo International Inc | Q2 2026 | +30.3 % | +16.4 % |
Sign in to see all peers for Scientific Industries Inc .
Scientific Industries Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Scientific Industries Inc | - | - | - |
| Thermo Fisher Scientific Inc | 6.36% | 7.71% | 13.37% |
| Enterprise Products Partners L p | 8.01% | 10.10% | 24.50% |
| Agilent Technologies inc | 10.97% | 19.84% | 41.99% |
| Illumina Inc | 12.68% | 19.61% | 31.08% |
| Mettler toledo International Inc | 24.86% | 34.41% | - |
Sign in to see all peers for Scientific Industries Inc .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Scientific Industries Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Scientific Industries Inc | - | 1.56 |
| Thermo Fisher Scientific Inc | 36.52 | 5.43 |
| Enterprise Products Partners L p | 12.77 | 1.37 |
| Agilent Technologies inc | 34.56 | 6.73 |
| Illumina Inc | 50.92 | 9.26 |
| Mettler toledo International Inc | 34.91 | 7.54 |
| PEERS AVERAGE | 32.29 | 3.74 |
Sign in to see all peers for Scientific Industries Inc .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.